Buckingham Research Downgrades Teva Pharma (TEVA) to Neutral
Tweet Send to a FriendGet Alerts TEVA Hot Sheet
Price: $39.30 -0.86%
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade TEVA Now!
Buckingham Research downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral following today's 2013 guidance update.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $40.22 yesterday, with a 52 week range of $37.40-$46.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $40.22 yesterday, with a 52 week range of $37.40-$46.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Maxim Group Starts Teva Pharma (TEVA) at Buy
- UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
Buckingham Research
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
